Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Auto-Allo HCT for Poor Risk DLBCL
NCT00482053Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Oct 2006
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in diffuse large B-cell lymphoma (DLBCL), sponsored by Stanford University. Started Oct 2006; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00482053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482053.